Aldeyra Therapeutics Inc. (ALDX)
NASDAQ · Healthcare
Aldeyra Therapeutics Inc. Long Term Debt 2020–2025
Aldeyra Therapeutics Inc. annual long term debt history from 2020 to 2024. Long term debt refers to financial obligations that are due more than one year in the future.
- Aldeyra Therapeutics Inc. long term debt as of December 31, 2024: 15.0M, a 5422.20% increase year-over-year.
- Aldeyra Therapeutics Inc. long term debt for 2024 were 15.0M, a 5422.20% increase from 2023.
- Aldeyra Therapeutics Inc. long term debt for 2023 were 271,631, a 98.18% decrease from 2022.
- Aldeyra Therapeutics Inc. long term debt for 2022 were 14.9M, a 4.52% decrease from 2021.
- Aldeyra Therapeutics Inc. long term debt for 2021 were 15.6M.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Aldeyra Therapeutics Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2024 | $15 |
| 2023 | $0 |
| 2022 | $15 |
| 2021 | $16 |
| 2020 | $11 |
Aldeyra Therapeutics Inc. Long Term Debt — FAQ
Aldeyra Therapeutics Inc. (ALDX) long term debt over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ALDX's long term debt history?
The chart and table above show Aldeyra Therapeutics Inc.'s long term debt by year and by quarter, including the growth rate.